Novartis acquires a gene-therapy company Gyroscope Therapeutics


Deprecated: strlen(): Passing null to parameter #1 ($string) of type string is deprecated in /home/medicircle/public_html/script_newsdetails.php on line 75
▴
Swiss healthcare giant Novartis has agreed to pay $1.5 billion to acquire British biotech company Gyroscope Therapeutics.

Swiss healthcare giant Novartis has agreed to pay $1.5 billion to acquire British biotech company Gyroscope Therapeutics. This acquisition will help the former to expand its offerings to include gene therapies for the eyes. Syncona, Gyroscope’s parent company, found their shares rising by 12.2%

For the deal, Novartis will pay an upfront payment of $800. Scope for further payment of an additional $700 million is possible if Gyroscope fulfils certain milestones. Novartis gets access to Gyroscope's gene therapy for geographic atrophy.

Novartis has been acquiring startups that have the technology to restore vision by gene therapies. Earlier this year, it acquired Arctos Medical and the year before that Vedere Bio Inc. for $280 million.

In recent years, gene therapy has garnered much attention. Pfizer is conducting experiments with gene therapy for a rare neuromuscular disease. One of the problems limiting this field is its high price tag. 

Gene therapies are currently among the world's most expensive drugs. Another drawback of this area is the lack of a safety net. Pfizer had to pull a stop to their experiments due to the deaths of young study subjects.

Tags : #Novartis #Gyroscope #funding #startup #genomics #genetherapy #smitakumar #medicircle

Related Stories

Loading Please wait...

-Advertisements-




Trending Now

AI-Enabled Endoscopy: Can It Detect More Than the Human Eye?November 20, 2026
AI-Enabled Endoscopy: Can It Detect More Than the Human Eye?November 20, 2026
Hospital-at-Home in India: Can Technology Deliver Safe Care?November 20, 2026
Digital Identity Fraud in Healthcare: What India Must KnowNovember 18, 2026
Wearables in Clinical Care: When Should Doctors Trust the Data?November 18, 2026
Cybersecurity for Medical Startups: What Founders MissNovember 18, 2026
Remote Patient Monitoring: The Next Phase of Virtual CareNovember 18, 2026
Digital Health Wallets: Future of Medical Records in IndiaNovember 17, 2026
How Hospitals Can Prepare for a Transparent Healthcare MarketNovember 17, 2026
Childhood Nutrition: Understanding Micronutrient Gaps Beyond CaloriesNovember 16, 2026
Anaemia in Adolescent Girls: Connecting Prevention, Testing and Nutrition SupportNovember 16, 2026
Health Information Exchanges in India: Are Medical Records Finally Going Portable?November 16, 2026
Hospital Accreditation in 2026: What Is Changing Beyond the Checklist?November 16, 2026
Digital Insurance Platforms and India's Health Coverage FutureNovember 14, 2026
ABDM 2.0: India's Digital Health Ecosystem FutureNovember 14, 2026
Vaccine Cold-Chain Management: Protecting Immunisation Quality From Storage to DeliveryNovember 14, 2026
Foodborne Illness Surveillance: How Public Health Systems Track RisksNovember 14, 2026
Interoperability in Indian Healthcare: Why Patient Data Still StrugglesNovember 13, 2026
Tuberculosis Contact Screening: How Preventive Care Works Around ExposureNovember 13, 2026
COPD Care in India: Linking Diagnosis, Inhaler Education and Follow-UpNovember 13, 2026